BlackDoctor14d
Ask a Black Doctor: Navigating Chronic Myeloid Leukemia
Dr. Ruemu Birhiray explains chronic myeloid leukemia (CML), its treatment options, and what patients should know about this ...
Targeted Oncology16d
CPX-351 vs 7+3: AML-MR Mutations Drive the Benefit of CPX-351 Over 7+3
With the Oncology Brothers, Uma Borate, MD, discusses how CPX-351 demonstrates superior efficacy over 7+3 chemotherapy in ...
News Medical on MSN16d
New approach in fighting leukemia with double-modified natural killer cells
One common form of leukemia is acute myeloid leukemia (AML), characterized by a degradation of early blood cell precursors, i ...
Targeted Oncology16d
Overview of KOMET-007: Ziftomenib Use in NPM-1m or KMT2A-r AML
With the Oncology Brothers, Uma Borate, MD, discusses how ziftomenib is showing promising results as a targeted therapy for ...